CD8A and neoplasm: PD-L1 is expressed on the surface of various tumor cells and has the ability to bind to PD-1 receptors of CD4+ and CD8+ T Cells thus altering proliferation and cytokine production, leading to T cell inactivation and apoptosis of these important cellular players of adaptive immunity.